Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Lechner, H; Ott, E; Bertha, G.
Therapeutical aspects of cerebrovascular disease.
EUR NEUROL. 1983; 22 Suppl 1: 74-77.
Doi: 10.1159/000115653
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
- Ott Erwin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Treatment of hemorheologic alterations in patients with CVD must be directed to reduce enhanced platelet and red cell aggregation, to improve reduced red cell deformability, and to control plasmatic hypercoagulability.
- Find related publications in this database (using NLM MeSH Indexing)
- Aspirin - therapeutic use
- Blood Coagulation - therapeutic use
- Cerebrovascular Disorders - therapy
- Clofibrate - therapeutic use
- Dipyridamole - therapeutic use
- Erythrocyte Aggregation - therapeutic use
- Erythrocytes - drug effects
- Humans - drug effects
- Ischemic Attack, Transient - prevention and control
- Pentoxifylline - pharmacology
- Plasma - physiology
- Platelet Aggregation - physiology
- Sulfinpyrazone - therapeutic use